Less vasopressors for heart shock on ECMO
Part of Heart & circulation clinical trials.
This trial is studying whether using less of the medicines that raise blood pressure (vasopressors) can help people with severe heart failure who are on a heart-lung machine (ECMO) survive. It may answer if a gentler approach is safer.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have cardiogenic shock (a severe heart failure that lowers blood flow) and are on a heart-lung machine called VA-ECMO.
- This is your first time being on ECMO.
- You do not have severe pulmonary hypertension (very high blood pressure in the lungs).
- Any medicines you take to raise blood pressure are for your heart shock, not for other reasons.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a device that helps the heart pump blood when it is too weak to do so, even with medicine, after surgery, or while waiting for a transplant. It aims to see if it's safe and works well.
This study tests whether adjusting the blood flow rate of an ECMO machine (which helps your heart pump) can improve blood flow to your organs and reduce stress on your heart during the critical early phase of cardiogenic shock. It aims to find the best ECMO settings to help you recover.
This trial studies people who are starting ECMO, a machine that takes over the work of the heart and lungs, to see if a more tailored approach can improve outcomes. If you join, your care may be adjusted based on your specific needs.
This trial tests if unloading the heart during ECMO support helps patients recover better from cardiogenic shock. It compares different ways to reduce the heart's workload.
This trial studies whether using a life-support machine called ECMO (extra support for the heart and lungs) helps people who develop shock right after a heart attack. It aims to improve outcomes when blood flow is failing and organs may be struggling.
This trial tests a device that helps support your heart when it's in cardiogenic shock (a life-threatening condition where the heart can't pump enough blood). The device works alongside standard treatments to improve blood flow and reduce strain on the heart.
Hear when a new Cardiogenic Shock trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.